Endocrine Cancer: Clinical Trials

1 trial for Endocrine Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Endocrine Cancer: new trials by email Literature Review of Endocrine Cancer trials Research Report on Endocrine Cancer

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
AMG 479, Placebo, gemcitabine - Adenocarcinoma of the Pancreas, Advanced Solid Tumors
Phase 3CompletedNantCell, Inc.8002011-04-072024-07-16

Narrower conditions

Endocrine Gland Neoplasms (1)  ·  Jaundice (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Hyperbilirubinemia (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Pancreatic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Skin Manifestations (1)

Interventions

Gemcitabine (1)  ·  ganitumab (1)

Sponsors

NantCell, Inc. (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Italy (1)